Scientific advice and protocol assistance adopted during the CHMP meeting 19-22 May 2025
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 September 2025, 14:00 (CEST) to 18 September 2025, 15:00 (CEST)
Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 14 October 2025, 14:00 (CEST) to 14 October 2025, 15:00 (CEST)
Q&A clinic on Substance, Organisation, Referentials Management Services, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 13 October 2025, 11:00 (CEST) to 13 October 2025, 12:00 (CEST)
Q&A clinic on Substance, Organisation, Referentials Management Services, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 10 November 2025, 11:00 (CET) to 10 November 2025, 12:00 (CET)
EMEA-003462-PIP01-23
EMEA-003572-PIP01-23
Opinion/decision on a Paediatric investigation plan (PIP): Aspaveli, Pegcetacoplan, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Renal and urinary disorders, PIP number: P/0195/2024
List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)
Scientific advice and protocol assistance adopted during the CHMP meeting 16-19 June 2025